Frontiers in Operations: Optimal Genetic Testing of Families

References

• Abbott B (2023) Cancer runs in families. Too few are getting tested. Wall Street Journal (August 29), A3.Google Scholar
• Alagoz O, Maillart LM, Schaefer AJ, Roberts MS (2004) The optimal timing of living-donor liver transplantation. Management Sci. 50(10):1420–1430.Link, Google Scholar
• Bergin J (2019) DNA sequencing market: Size, trends, share & research report. Technical report, BCC Research, Wellesley, MA.Google Scholar
• Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, et al. (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J. Clinical Oncology 20(11):2701–2712.Google Scholar
• Carey DJ, Fetterolf SN, Davis FD, Faucett WA, Kirchner HL, Mirshahi U, Murray MF, Smelser DT, Gerhard GS, Ledbetter DH (2016) The Geisinger MyCode Community Health Initiative: An electronic health record-linked biobank for Precision Medicine research. Genetics Medicine 18(9):906–913.Google Scholar
• Center for the Evaluation of Value and Risk in Health (2020) The cost-effectiveness analysis registry. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center. Accessed April 17, 2020, www.cearegistry.org.Google Scholar
• Chen J, Bae E, Zhang L, Hughes K, Parmigiani G, Braun D, Rebbeck TR (2020) Penetrance of breast and ovarian cancer in women who carry a BRCA1/2 mutation and do not use risk-reducing salpingo-oophorectomy: An updated meta-analysis. JNCI Cancer Spectrum 4(4):pkaa029.Google Scholar
• Chen S, Wang W, Broman KW, Katki HA, Parmigiani G (2004) BayesMendel: An R environment for Mendelian risk prediction. Statist. Appl. Genetics Molecular Biology 3(1).Google Scholar
• Chhatwal J, Alagoz O, Burnside ES (2010) Optimal breast biopsy decision-making based on mammographic features and demographic factors. Oper. Res. 58(6):1577–1591.Link, Google Scholar
• Cooper GF (1990) The computational complexity of probabilistic inference using Bayesian belief networks. Artificial Intelligence 42(2):393–405.Crossref, Google Scholar
• Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, et al. (2021) Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J. Natl. Comprehensive Cancer Network 19(1):77–102.Google Scholar
• Drakopoulos K, Randhawa RS (2021) Why perfect tests may not be worth waiting for: Information as a commodity. Management Sci. 67(11):6678–6693.Link, Google Scholar
• El Hajj H, Bish DR, Bish EK, Kay DM (2022) Novel pooling strategies for genetic testing, with application to newborn screening. Management Sci. 68(11):7994–8014.Link, Google Scholar
• Guzauskas GF, Garbett S, Zhou Z, Spencer SJ, Smith HS, Hao J, Hassen D, et al. (2020) Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States. JAMA Network Open 3(10):e2022874.Google Scholar
• Koller D, Friedman N (2009) Probabilistic Graphical Models: Principles and Techniques (MIT Press, Cambridge, MA).Google Scholar
• Kong N, Zhang S, eds. (2018) Decision Analytics and Optimization in Disease Prevention and Treatment (Wiley, Hoboken, NJ).Crossref, Google Scholar
• Kschischang FR, Frey BJ, Loeliger H (2001) Factor graphs and the sum-product algorithm. IEEE Trans. Inform. Theory 47(2):498–519.Crossref, Google Scholar
• Lee HK, Li J, Bain PA, Baker C (2022) Optimal intervention policies for total joint replacement postoperative care process. Manufacturing Service Oper. Management 24(1):617–631.Link, Google Scholar
• Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA (2019) Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann. Surgical Oncology 26(10):3025–3031.Google Scholar
• Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, et al. (2015) Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. J. Natl. Cancer Inst. 107(1):380.Google Scholar
• Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, et al. (2018) Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. J. Natl. Cancer Inst. 110(7):714–725.Google Scholar
• Mayo Clinic (2021) Center for Individualized Medicine—Genomic Sequencing: Tapestry Study (Mayo Clinic, Rochester, MN).Google Scholar
• Mendel G (1866) Experiments in Plant Hybridisation (Royal Horticultural Society, London).Google Scholar
• Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, Stewart DR, et al. (2021) ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genetics Medicine 23(8):1381–1390.Google Scholar
• Mills A, Ziya S (2021) Testing with limited capacity and pooling. Preprint, submitted March 18, https://papers.ssrn.com/abstract=3689028.Google Scholar
• Nohdurft E, Long E, Spinler S (2017) Was Angelina Jolie right? Optimizing cancer prevention strategies among BRCA mutation carriers. Decision Anal. 14(3):139–169.Link, Google Scholar
• Oliveri S, Ferrari F, Manfrinati A, Pravettoni G (2018) A systematic review of the psychological implications of genetic testing. Frontiers Genetics 9:624.Crossref, Google Scholar
• Örmeci EL, Güneş ED, Kunduzcu D (2016) A modeling framework for control of preventive services. Manufacturing Service Oper. Management 18(2):227–244.Google Scholar
• Paulden M (2020) Calculating and interpreting ICERs and net benefit. PharmacoEconomics 38(8):785–807.Google Scholar
• Pearl J (1982) Reverend Bayes on inference engines: A distributed hierarchical approach. Proc. Natl. Conf. Artificial Intelligence (AAAI Press, Palo Alto, CA), 133–136.Google Scholar
• Phillips KA, Deverka PA, Hooker GW, Douglas MP (2018) Genetic test availability and spending: Where are we now? Where are we going? Health Affairs 37(5):710–716.Crossref, Google Scholar
• Puterman ML (1994) Markov Decision Processes: Discrete Stochastic Dynamic Programming (John Wiley & Sons, Inc., New York).Crossref, Google Scholar
• Rand LZ, Kesselheim AS (2021) Controversy over using quality-adjusted life-years in cost-effectiveness analyses: A systematic literature review. Health Affairs 40(9):1402–1410.Crossref, Google Scholar
• Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E (2013) ACMG clinical laboratory standards for next-generation sequencing. Genetics Medicine 15(9):733–747.Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, et al. (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics Medicine 17(5):405–423.Google Scholar
• Robbins R (2019) Top U.S. medical centers roll out DNA sequencing clinics for healthy clients. Scientific American (August 18), https://www.scientificamerican.com/article/top-u-s-medical-centers-roll-out-dna-sequencing-clinics-for-healthy-clients/.Google Scholar
• Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, et al. (2018) Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J. Amer. College Cardiology 72(6):662–680.Google Scholar
• Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, et al. (2019) 10-year performance of four models of breast cancer risk: A validation study. Lancet Oncology 20(4):504–517.Google Scholar
• The 100000 Genomes Project Pilot Investigators (2021) 100,000 Genomes pilot on rare-disease diagnosis in healthcare—Preliminary report. New England J. Medicine 385(20):1868–1880.Crossref, Google Scholar
• Toriello A, Haskell WB, Poremba M (2014) A dynamic traveling salesman problem with stochastic arc costs. Oper. Res. 62(5):1107–1125.Link, Google Scholar
• U.S. Census Bureau (2012) Census 2000 data for the United States. Report, U.S. Census Bureau, Washington, DC.Google Scholar
• U.S. Census Bureau (2020) Historical households tables. Report, U.S. Census Bureau, Washington, DC.Google Scholar
• US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement. JAMA 322(7):652.Google Scholar
• Weiler N (2020) Free genome sequencing now available to all UCSF patients. Accessed October 11, 2020, https://www.ucsf.edu/news/2020/08/418286/free-genome-sequencing-now-available-all-ucsf-patients.Google Scholar